Eisai
4523.T
#1927
Rank
C$11.84 B
Marketcap
$42.01
Share price
0.67%
Change (1 day)
-40.98%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

P/E ratio for Eisai (4523.T)

P/E ratio as of November 2024 (TTM): 13.8

According to Eisai's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 13.7611. At the end of 2022 the company had a P/E ratio of 39.3.

P/E ratio history for Eisai from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202239.3378.54%
20218.2245.73%
20205.64-7.26%
20196.08-36.35%
20189.55-39.55%
201715.881.33%
20168.71-32.1%
201512.881.67%
20147.062.2%
20136.9116.77%
20125.9228.37%
20114.6118.41%
20103.89-0.22%
20093.90

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.